Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
Pharma company Viiv’s attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

People living with HIV have opposed patent applications in India for two important HIV medicines, dolutegravir and cabotegravir. Médecins Sans Frontières/ Doctors Without Borders (MSF) supports these ‘patent oppositions,’ which have been filed to challenge an attempt by ViiV Healthcare (a joint venture by Pfizer and GlaxoSmithKline) to obtain monopoly rights in India while several of its patent claims are questionable according to Indian patentability criteria.

Published
11 February 2016
From
Médecins Sans Frontières
Are States Obligated To Provide Expensive Hepatitis C Drugs?

A handful of federal lawsuits against states that have denied highly effective but costly hepatitis C drugs to Medicaid patients and prisoners could cost states hundreds of millions of dollars.

Published
10 February 2016
From
Kaiser Health News
How the AIDS Drug Assistance Program Boosts Health Insurance Access

An annual ADAP report shows the program serving 139,000 clients in June 2015 with a total budget of $2.24 billion.

Published
10 February 2016
From
Poz magazine news
African Americans have highest HIV incidence, lowest rate of consistent care

African Americans in the US have the highest rate of new HIV infections, but black people living with HIV are less likely than white or Latino

Published
08 February 2016
By
Liz Highleyman
Fair Pricing Coalition Recognizes Merck’s Lower Price for Curative Hepatitis C Treatment, Calls for Manufacturers to Reduce Excessive Prices and Increase Patient Assistance

The Fair Pricing Coalition (FPC) today expressed appreciation for Merck’s & Co. Inc.’s decision to launch its new curative hepatitis C (HCV) treatment, Zepatier, at a price below existing HCV treatments in a tacit acknowledgement that existing high prices have hurt patients and are untenable for the market. Zepatier’s $54,600 list price is lower than the egregious prices for Gilead Sciences’ Harvoni ($94,500) and AbbVie’s Viekira Pak ($83,319), and represents a step in the right direction.

Published
08 February 2016
From
Fair Pricing Coalition
CDC: Blacks with HIV less likely to receive consistent medical care

Blacks with HIV are less likely than whites and Hispanics to receive consistent medical care, according to a new report by the Centers for Disease Control and Prevention.

Published
05 February 2016
From
Atlanta Journal Constitution
Pennsylvania to Offer Free Hepatitis C Treatment to Low-Income People With HIV

The $13 million, six-month program  is expected to aid hundreds of low-income people over 65 years old in the state.

Published
05 February 2016
From
Poz magazine news
Migrant women face £6,000 birth bill under 'health tourism' laws

Charities say undocumented women have to make difficult choices about accessing maternity care because of crippling NHS fees.

Published
04 February 2016
From
The Guardian
Lawsuits claim insurers unfairly refuse pricey hepatitis C drugs

Two Washington state insurers — Group Health Cooperative and BridgeSpan — are targeted in class-action lawsuits that claim the companies are unfairly rationing new drugs that can cure hepatitis C based on high cost, not medical need.

Published
03 February 2016
From
Seattle Times
Lawmaker: Costly hepatitis C drug "a slap in the face to veterans"

A Congressional hearing will begin Wednesday in response to a CBS News investigation, where we showed how a costly new cure for hepatitis C isn't making it to most of the 200,000 U.S. veterans infected with the disease, many as a result of their service. Congress has given $2.7 billion taxpayer to treat veterans with hepatitis C, but only 15 percent have been treated with the drug, one that might not exist without government funding.

Published
03 February 2016
From
CBS News
← First12345...104Next →

Filter by country